Retrospective Cohort Study
Copyright ©The Author(s) 2025.
World J Hepatol. Mar 27, 2025; 17(3): 103261
Published online Mar 27, 2025. doi: 10.4254/wjh.v17.i3.103261
Table 4 Univariate and multivariate Cox regression analyses for hepatocellular carcinoma before and after propensity score matching
Characteristics
Before PSM, univariate analyses (n = 815)
Before PSM, multivariate analyses (n = 815)
After PSM, univariate analyses (n = 662)
After PSM, univariate analyses (n = 662)
HR
95%CI
P
HR
95%CI
P
HR
95%CI
P
HR
95%CI
P
Group B0.3320.154-0.7130.005b0.370.171-0.8000.012a0.3460.149-0.8020.013a0.3740.160-0.8740.023a
Creatinine3.0981.406-6.8280.005b2.1440.868-5.2970.0983.0911.434-6.6620.004b3.2531.442-7.3400.004b
Prothrombin time activity0.5930.293-1.2010.1470.1780.039-0.8130.026a0.1280.026-0.6230.011a
Pre-TIPS MELD score58.7751.249-2766.7720.038a13.3670.160-1115.6080.251
Female0.4220.163-1.0930.075
Alanine aminotransferase0.630.377-1.0530.078
Pre-TIPS inferior vena cava pressure0.5790.281-1.1930.139
White blood cell count0.6350.337-1.1940.159
Chlorine26.6880.261-2726.9170.164
Blood ammonia0.7370.390-1.3930.348
C-reactive protein1.0580.931-1.2030.387
Hemoglobin1.590.402-6.2880.508